"These studies, taken together, offer important insight into the direction we should be heading in prostate cancer diagnosis: toward a targeted-only TP biopsy," write Tarik Benidir, MD, and Zeyad Schwen, MD.
Tarik Benidir, MD
Advertisement
Benidir is a urologic oncology fellow at Cleveland Clinic Glickman Urological and Kidney Institute in Ohio.
Articles by Tarik Benidir, MD
Advertisement
Latest Updated Articles
The safety and oncologic benefits of transperineal vs transrectal MRI-guided prostate biopsyPublished: March 27th 2023 | Updated:
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures
2
Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC
3
Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study
4
BOND-003: Cretostimogene yields durable 24-month responses in high-grade NMIBC
5
